| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |